Dennis J. Carlo
2015
In 2015, Dennis J. Carlo earned a total compensation of $1.8M as President and Chief Executive Officer at Adamis Pharmaceuticals, a 180% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $137,500 |
|---|---|
| Option Awards | $1,090,884 |
| Salary | $550,000 |
| Other | $21,814 |
| Total | $1,800,198 |
Carlo received $1.1M in option awards, accounting for 61% of the total pay in 2015.
Carlo also received $137.5K in non-equity incentive plan, $550K in salary and $21.8K in other compensation.
Rankings
In 2015, Dennis J. Carlo's compensation ranked 5,153rd out of 13,638 executives tracked by ExecPay. In other words, Carlo earned more than 62.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,153 out of 13,638 | 62nd |
Division Manufacturing | 1,903 out of 5,187 | 63rd |
Major group Chemicals And Allied Products | 687 out of 1,857 | 63rd |
Industry group Drugs | 546 out of 1,531 | 64th |
Industry Pharmaceutical Preparations | 429 out of 1,179 | 64th |
Source: SEC filing on May 1, 2017.
Carlo's colleagues
We found two more compensation records of executives who worked with Dennis J. Carlo at Adamis Pharmaceuticals in 2015.